Remedy Meds to Acquire Thirty Madison in All-Stock Deal Valued at Over $500 Million

September 8, 2025

Remedy Meds announced a definitive agreement to acquire Thirty Madison in an all-stock transaction valued at just over $500 million. The deal is expected to close in the fourth quarter of 2025, pending regulatory approvals and standard closing conditions.

Buyers
Remedy Meds
Targets
Thirty Madison
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.